News from the healthcare data industry
November 03, 2022 06:00 ET | Source: Centogene NV CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 03, 2022 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science partner for...
A partnership between Syntegra and Atropos Health, a startup company providing physicians with real-world evidence at the point of care, will enable users of Atropos Health’s Green Button Informatics Consult...
Mountain View, California, Nov. 01, 2022 (GLOBE NEWSWIRE) — Health Gorilla, a leading Health Information Network and interoperability provider, has been selected by MEDITECH as the technology platform for Traverse Exchange...
TORONTO and OTTAWA, ON, Nov. 1, 2022 /PRNewswire/ – Innovate Cities is proud to announce our partnership with Canadian technology provider Replica Analytics, an Aetion company. Replica Analytics is the premier technology- based Synthetic...
– Using Invitae’s Ciitizen patient-driven data platform, AstraZeneca and the Cholangiocarcinoma Foundation will access lived experience of patients with a rare cancer to drive further research – – Real-world insights...
Israel health centers leverage Lynx MD medical platform to securely share data with MedTech, Pharmaceutical and AI researchers to transform patient care Our collaboration with Lynx will allow faster and...
The Research Institute of the McGill University Health Centre (RI-MUHC), in partnership with the Faculty of Medicine and Health Sciences (FMHS) and the Departments of Surgery and Medicine at McGill...
ESTERO, Fla. and DENVER, Oct. 19, 2022 /PRNewswire/ — Hertz (NASDAQ: HTZ) and Palantir Technologies Inc. (NYSE: PLTR, “Palantir”), a leading builder of operating systems for the modern enterprise, today announced a multi-year partnership to help...
DURHAM, N.C., Oct. 18, 2022 /PRNewswire/ — Today, real world evidence (RWE) leader Target RWE announced a partnership with the American Association for the Study of Liver Diseases (AASLD) to support its Cirrhosis Quality Collaborative (CQC),...
GSK plc (LSE/NYSE: GSK) and Tempus, a US-based precision medicine company, have entered into a three-year collaboration agreement that provides GSK with access to Tempus’ AI-enabled platform, including its library...